Structure of Prion Protein Amyloid Fibrils As Determined By

Total Page:16

File Type:pdf, Size:1020Kb

Structure of Prion Protein Amyloid Fibrils As Determined By STRUCTURE OF PRION PROTEIN AMYLOID FIBRILS AS DETERMINED BY HYDROGEN/DEUTERIUM EXCHANGE by XIAOJUN LU Submitted in partial fulfillment of the requirements For the degree of Doctor of Philosophy Dissertation Adviser: Dr. Witold K. Surewicz Department of Chemsitry CASE WESTERN RESERVE UNIVERSITY May, 2008 CASE WESTERN RESERVE UNIVERSITY SCHOOL OF GRADUATE STUDIES We hereby approve the thesis/dissertation of _____________________________________________________ candidate for the ______________________degree *. (signed)_______________________________________________ (chair of the committee) ________________________________________________ ________________________________________________ ________________________________________________ ________________________________________________ ________________________________________________ (date) _______________________ *We also certify that written approval has been obtained for any proprietary material contained therein. To My Family ii TABLE OF CONTENTS Page Table of Contents iii List of Tables vii List of Figures viii Acknowledgements xi List of Abbreviations xii Abstract xv Chapter 1: Prion Diseases 1 1.1 Amyloidosis 1 1.1.1 Amyloidoses 1 1.1.2 Amyloid 1 1.2 Prion diseases 3 1.3 Protein-only hypothesis 6 1.3.1 Historical overview of prion theory 6 1.3.2 “Protein-only” hypothesis 7 1.3.3 Evidence in support of the protein-only hypothesis 8 1.3.4 Prion strains and species barriers 10 1.4 PrPC 12 1.4.1 The structure of PrPC 12 iii 1.4.2 The physiological function of PrPC 13 1.4.3 Familial mutations associated with the PRNP gene 15 1.5 PrPSc 17 1.5.1 Current knowledge about PrPSc structure 17 1.5.2 In vitro conversion studies 19 1.5.3 Current structural models for PrPSc 21 1.6 Fungal prions 23 Chapter 2: Hydrogen-Deuterium Exchange 26 2.1 Background 26 2.1.1 Theory 26 2.1.2 Historical perspective 29 2.2 Techniques 33 2.2.1 Labeling 33 2.2.2 Rapid proteolysis 33 2.2.3 Fragment separation 34 2.2.4 MS measurement 35 2.2.5 Data analysis 35 2.3 Current application of HXMS to amyloid fibrils 36 2.3.1 Amyloid-β 36 2.3.2 α-Synuclein 37 iv 2.3.3 HET-s protein 37 Chapter 3: Structure of Wild-type HuPrP90-231 Amyloid Fibrils 39 3.1 Introduction 39 3.2 Materials and methods 40 3.2.1 Protein purification 40 3.2.2 Spontaneous conversion of PrP to amyloid fibrils 42 3.2.3 ThT assay 42 3.2.4 AFM 43 3.2.5 Annealing 43 3.2.6 Peptide mapping 43 3.2.7 Hydrogen/deuterium exchange 44 3.3 Results 48 3.3.1 Peptide mapping and coverage 48 3.3.2 H/D exchange data for the soluble monomer 50 3.3.3 H/D exchange on amyloid fibrils 53 3.3.4 Effect of fibril annealing on the pattern of H/D exchange 56 3.4 Discussion 60 Chapter 4: Structure of D178N HuPrP90-231 Amyloid Fibrils 67 4.1 Introduction 67 4.2 Materials and methods 67 v 4.3 Results 68 4.3.1 Optimization of digestion conditions 68 4.3.2 Peptide mapping and coverage 70 4.3.3 H/D exchange of amyloid fibrils 71 4.4 Discussion 74 Chapter 5: Structure of ShaPrP90-231 Amyloid Fibrils 78 5.1 Introduction 78 5.2 Materials and methods 80 5.2.1 Protein expression and purification 80 5.2.2 Preparation and characterization of amyloid fibrils 80 5.2.3 Hydrogen/deuterium exchange 81 5.2.4 Bimodal distribution 81 5.3 Results 82 5.3.1 Peptide mapping and coverage 82 5.3.2 H/D exchange data for the monomer 83 5.3.3 H/D exchange on spontaneously converted amyloid fibrils 83 5.3.4 H/D exchange on PrPPMCA 88 5.4 Discussion 93 Chapter 6: Future Directions 98 Bibliography 103 vi LIST OF TABLES Page Table 1.1. Human amyloid (or aggregate) proteins and their associated diseases 2 Table 1.2. The prion diseases 4 Table 3.1. Peptic fragments from wild-type huPrP90-231 that were used in HXMS experiments 49 Table 5.1. Peptic fragments from ShaPrP90-231 used in HXMS experiments 84 vii LIST OF FIGURES Page Figure 1.1. The solution structure of human PrP 14 Figure 1.2. Pathogenic mutations associated with the PRNP gene 16 Figure 1.3. Left handed β–helical model 22 Figure 1.4. Spiral model 24 Figure 2.1. Rate constant for isotopic exchange of hydrogen located on peptide amide linkages in polyalanine presented as a function of pH 28 Figure 2.2. The resulting MS spectra of the two kinetic limits, EX2 and EX1 30 Figure 3.1. MS/MS spectrum of peptides FTETDVKM (residues 198-205 of huPrP) 45 Figure 3.2. Overview of HXMS experimental procedure for amyloid fibrils 46 Figure 3.3. MS spectra of double-charged peptide 198–207 illustrating time-dependent deuterium uptake 51 Figure 3.4. Kinetic curves for deuterium incorporation by individual peptic fragments for huPrP90–231 monomer and amyloid fibrils 52 Figure 3.5. Characterization of amyloid fibrils of huPrP90–231 54 Figure 3.6. H/D exchange protection maps summarizing 25-h exchange data for huPrP90–231 fibrils before and after annealing 57 Figure 3.7. PK digestion of huPrP90–231 fibrils before and after annealing 59 viii Figure 4.1. Optimization of digestion conditions 69 Figure 4.2. Typical amyloid fibrils of D178N huPrP90–231 as seen by atomic force microscopy 72 Figure 4.3. H/D exchange protection maps summarizing 25-h exchange data for D178N huPrP90–231 fibrils 73 Figure 4.4. The simplest model of recombinant PrP amyloid consistent with EPR experimental data 77 Figure 5.1. Kinetic curves for deuterium incorporation by individual peptic fragments for ShaPrP90–231 monomer , spontaneously converted amyloid fibrils and the PMCA product 85 Figure 5.2. Typical spontaneously converted amyloid fibrils of ShaPrP90–231 as seen by atomic force microscopy 87 Figure 5.3. MS spectra of doubly-charged peptic fragment 145-154 illustrating the bimodal envelopes of isotope peaks 89 Figure 5.4. Deuterium incorporation of all peptic fragments for ShaPrP90–231 fibrils after 2 h and 25 h of exchange 91 Figure 5.5. The fractions of highly protected species for different peptic fragments in the PMCA product formed by ShaPrP90-231 92 Figure 5.6. H/D exchange protection maps summarizing 25-h exchange data for spontaneously converted amyloid fibrils and highly protected ix PrPPMCA species formed by ShaPrP90-231 94 Figure 5.7. In vitro conversion of recombinant Sha 90-231 to PK-resistant form by PMCA seeded with purified PrPSc from 263K-infected hamster brain 97 Figure 6.1. Peptide mapping for wild-type huPrP90-231 digested by protease type XVIII at enzyme/protein ratio (wt/wt) of 4 100 x ACKNOWLEDGEMENTS First and most importantly, I would like to thank my advisor Dr. Witold Surewicz. Without his continued support and guidance, I couldn’t have finished this work. I would also like to acknowledge my committee members including Dr. Irene Lee, Dr. Mary Barkley, Dr. James Burgess and Dr. Patrick Wintrode for their critical review of my doctoral work. I want to express many thanks to my colleagues: to Dr. Krystyna Surewicz, for her continued encouragement and help; to Dr. Jonathan Cannon and Dr. Nathan Cobb, for proofreading this thesis; to Dr. Jae-Il Kim, for preparing all PMCA samples for me; to all former members of the Surewicz lab, particularly to Drs. David Vanik, Bishwajit Kundu, Constantin Adrian Apetri and Eric Jones for all time we spent together. I would also like to thank Dr. Patrick Wintrode and his student Yuko Tsutsui, for their help on my projects; to my co-advisor Dr.Michael Zagorski, for introducing me to amyloid field. xi LIST OF ABBREVIATION Aβ Amyloid-β AFM Atomic force microscopy BSE Bovine spongiform encephalopathy CID Collision induced dissociation CJD Creutzfeldt–Jakob disease CWD Chronic wasting disease D178N Aspartic acid to asparagine substitution at position 178 EPR Electron paramagnetic resonance ESI Electrospray ionization FAB Fast atom-bombardment FFI Fatal familial insomnia FT-ICR Fourier transform ion cyclotron resonance GPI Glycosylphosphatidylinositol GSS Gerstmann–Sträussler–Scheinker syndrome GdnHCl Guanidine hydrochloride HPLC High-performance liquid chromatography Hu Human HX Hydrogen/deuterium exchange IPTG Isopropyl-β-D-thiogalactopyranoside xii LB Luria Bertani MALDI Matrix-assisted laser desorption ionization mo Mouse MS Mass spectrometry MS/MS Tandem mass spectrometry NMR Nuclear magnetic resonance PDB Protein Data Bank PK Proteinase K PMCA Protein misfolding cyclic amplification PMSF Phenylmethylsulphonyl fluoride PrP Prion protein PrP27-30 The 27-30 kDa fragment resulted from treatment of PrPSc with PK PrPC Prion protein, cellular conformer PrPPMCA The PMCA product formed by recombinant ShaPrP90-231 PrPSc Prion protein, scrapie-associated conformer PrPSp Spontaneously formed ShaPrP90-231 amyloid fibrils SDSL Site-directed spin labeling SDS-PAGE Sodium dodecyl sulfate polyacrylamide gel electrophoresis Sha Syrian hamster TCEP Tris (2-carboxyethyl) phosphine hydrochloride xiii TFA Trifluoroacetic acid ThT Thioflavine T TME Transmissible mink encephalopathy TSE Transmissible spongiform encephalopathy vCJD Variant Creutzfeldt–Jakob disease xiv Structure of Prion Protein Amyloid Fibrils as Determined by Hydrogen/Deuterium Exchange Abstract by Xiaojun Lu Propagation of transmissible spongiform encephalopathies is associated with the conversion of normal prion protein, PrPC, into a misfolded, oligomeric form, PrPSc. While the high-resolution structure of PrPC is well characterized, the structural properties of PrPSc remain elusive. Here we used mass spectroscopic analysis of hydrogen/deuterium backbone amide exchange (HXMS) to examine the structure of amyloid fibrils formed by the recombinant human prion protein corresponding to residues 90-231 (PrP90-231), a misfolded form recently reported to be infectious in transgenic mice overexpressing PrPC. Analysis of H/D exchange data allowed us to map the systematically hydrogen-bonded β-sheet core of PrP amyloid to the C-terminal region (starting at residue ~169) that in the native structure of the PrP monomer corresponds to α-helix 2, a major part of α-helix 3, and the loop between these two helices.
Recommended publications
  • Prpsc Prions State of the Art
    Sc PrP Prions State of the Art Edited by Joaquín Castilla and Jesús R. Requena Printed Edition of the Special Issue Published in Pathogens www.mdpi.com/journal/pathogens PrPSc Prions: State of the Art Sc PrP Prions: State of the Art Special Issue Editors Joaqu´ınCastilla Jes ´usR. Requena MDPI • Basel • Beijing • Wuhan • Barcelona • Belgrade Special Issue Editors Joaqu´ın Castilla Jes us´ R. Requena CIC bioGUNE University of Santiago de Compostela Spain Spain Editorial Office MDPI St. Alban-Anlage 66 Basel, Switzerland This is a reprint of articles from the Special Issue published online in the open access journal Pathogens (ISSN 2076-0817) from 2017 to 2018 (available at: https://www.mdpi.com/journal/pathogens/ special issues/prions study) For citation purposes, cite each article independently as indicated on the article page online and as indicated below: LastName, A.A.; LastName, B.B.; LastName, C.C. Article Title. Journal Name Year, Article Number, Page Range. ISBN 978-3-03897-308-9 (Pbk) ISBN 978-3-03897-309-6 (PDF) Cover image courtesy of Jesus´ R. Requena and Joaqu´ın Castilla. Articles in this volume are Open Access and distributed under the Creative Commons Attribution (CC BY) license, which allows users to download, copy and build upon published articles even for commercial purposes, as long as the author and publisher are properly credited, which ensures maximum dissemination and a wider impact of our publications. The book taken as a whole is c 2018 MDPI, Basel, Switzerland, distributed under the terms and conditions of the Creative Commons license CC BY-NC-ND (http://creativecommons.org/licenses/by-nc-nd/4.0/).
    [Show full text]
  • Podospora Anserina Bibliography N° 10 - Additions
    Fungal Genetics Reports Volume 50 Article 15 Podospora anserina bibliography n° 10 - Additions Robert Debuchy Université Paris-Sud Follow this and additional works at: https://newprairiepress.org/fgr This work is licensed under a Creative Commons Attribution-Share Alike 4.0 License. Recommended Citation Debuchy, R. (2003) "Podospora anserina bibliography n° 10 - Additions," Fungal Genetics Reports: Vol. 50, Article 15. https://doi.org/10.4148/1941-4765.1161 This Special Paper is brought to you for free and open access by New Prairie Press. It has been accepted for inclusion in Fungal Genetics Reports by an authorized administrator of New Prairie Press. For more information, please contact [email protected]. Podospora anserina bibliography n° 10 - Additions Abstract Podospora anserina is a coprophilous fungus growing on herbivore dung. It is a pseudohomothallic species in which ascus development results, as in Neurospora tetrasperma but through a different process, in the formation of four large ascospores containing nuclei of both mating types. This special paper is available in Fungal Genetics Reports: https://newprairiepress.org/fgr/vol50/iss1/15 Debuchy: Podospora anserina bibliography n° 10 - Additions Number 50, 2003 27 Podospora anserina bibliography n/ 10 - Additions Robert Debuchy, Institut de Génétique et Microbiologie UMR 8621, Bâtiment 400, Université Paris-Sud, 91405 Orsay cedex, France. Fungal Genet. Newsl. 50: 27-36. Podospora anserina is a coprophilous fungus growing on herbivore dung. It is a pseudohomothallic species in which ascus development results, as in Neurospora tetrasperma but through a different process, in the formation of four large ascospores containing nuclei of both mating types. These ascospores give self-fertile strains.
    [Show full text]
  • Prions As Protein-Based Genetic Elements
    14 Aug 2002 14:0 AR AR168-MI56-28.tex AR168-MI56-28.sgm LaTeX2e(2002/01/18) P1: IBD 10.1146/annurev.micro.56.013002.100603 Annu. Rev. Microbiol. 2002. 56:703–41 doi: 10.1146/annurev.micro.56.013002.100603 Copyright c 2002 by Annual Reviews. All rights reserved First published online as a Review in Advance on July 15, 2002 PRIONS AS PROTEIN-BASED GENETIC ELEMENTS Susan M. Uptain1 and Susan Lindquist2 1Howard Hughes Medical Institute, Department of Molecular Genetics and Cell Biology, University of Chicago, Chicago, Illinois 60637; e-mail: [email protected] 2Whitehead Institute for Biomedical Research, Department of Biology, Massachusetts Institute of Biology, Nine Cambridge Center, Cambridge, Massachusetts 02142; e-mail: lindquist [email protected] Key Words Sup35, Ure2, HET-s, Rnq1, amyloid ■ Abstract Fungal prions are fascinating protein-based genetic elements. They alter cellular phenotypes through self-perpetuating changes in protein conformation and are cytoplasmically partitioned from mother cell to daughter. The four prions of Saccharomyces cerevisiae and Podospora anserina affect diverse biological pro- cesses: translational termination, nitrogen regulation, inducibility of other prions, and heterokaryon incompatibility. They share many attributes, including unusual genetic behaviors, that establish criteria to identify new prions. Indeed, other fungal traits that baffled microbiologists meet some of these criteria and might be caused by prions. Recent research has provided notable insight about how prions are induced and prop- agated and their many biological roles. The ability to become a prion appears to be evolutionarily conserved in two cases. [PSI+] provides a mechanism for genetic vari- ation and phenotypic diversity in response to changing environments.
    [Show full text]
  • Ribosomal RNA Modulates Aggregation of the Podospora Prion Protein HET-S
    International Journal of Molecular Sciences Article Ribosomal RNA Modulates Aggregation of the Podospora Prion Protein HET-s Yanhong Pang y, Petar Kovachev and Suparna Sanyal * Department of Cell and Molecular Biology, Uppsala University, Box-596, Biomedical Center, 751 24 Uppsala, Sweden; [email protected] (Y.P.); [email protected] (P.K.) * Correspondence: [email protected] Present address: Department of Molecular Sciences, Uppsala Biocenter, Swedish University of Agricultural y Sciences, 750 07 Uppsala, Sweden. Received: 25 August 2020; Accepted: 28 August 2020; Published: 1 September 2020 Abstract: The role of the nucleic acids in prion aggregation/disaggregation is becoming more and more evident. Here, using HET-s prion from fungi Podospora anserina (P. anserina) as a model system, we studied the role of RNA, particularly of different domains of the ribosomal RNA (rRNA), in its aggregation process. Our results using Rayleigh light scattering, Thioflavin T (ThT) binding, transmission electron microscopy (TEM) and cross-seeding assay show that rRNA, in particular the domain V of the major rRNA from the large subunit of the ribosome, substantially prevents insoluble amyloid and amorphous aggregation of the HET-s prion in a concentration-dependent manner. Instead, it facilitates the formation of the soluble oligomeric “seeds”, which are capable of promoting de novo HET-s aggregation. The sites of interactions of the HET-s prion protein on domain V rRNA were identified by primer extension analysis followed by UV-crosslinking, which overlap with the sites previously identified for the protein-folding activity of the ribosome (PFAR). This study clarifies a missing link between the rRNA-based PFAR and the mode of propagation of the fungal prions.
    [Show full text]
  • Drivers of Evolutionary Change in Podospora Anserina
    Digital Comprehensive Summaries of Uppsala Dissertations from the Faculty of Science and Technology 1923 Drivers of evolutionary change in Podospora anserina SANDRA LORENA AMENT-VELÁSQUEZ ACTA UNIVERSITATIS UPSALIENSIS ISSN 1651-6214 ISBN 978-91-513-0921-7 UPPSALA urn:nbn:se:uu:diva-407766 2020 Dissertation presented at Uppsala University to be publicly examined in Ekmansalen, Evolutionary Biology Centre (EBC), Norbyvägen 18D, Uppsala, Tuesday, 19 May 2020 at 10:00 for the degree of Doctor of Philosophy (Faculty of Theology). The examination will be conducted in English. Faculty examiner: Professor Bengt Olle Bengtsson (Lund University). Abstract Ament-Velásquez, S. L. 2020. Drivers of evolutionary change in Podospora anserina. Digital Comprehensive Summaries of Uppsala Dissertations from the Faculty of Science and Technology 1923. 63 pp. Uppsala: Acta Universitatis Upsaliensis. ISBN 978-91-513-0921-7. Genomic diversity is shaped by a myriad of forces acting in different directions. Some genes work in concert with the interests of the organism, often shaped by natural selection, while others follow their own interests. The latter genes are considered “selfish”, behaving either neutrally to the host, or causing it harm. In this thesis, I focused on genes that have substantial fitness effects on the fungus Podospora anserina and relatives, but whose effects are very contrasting. In Papers I and II, I explored the evolution of a particular type of selfish genetic elements that cause meiotic drive. Meiotic drivers manipulate the outcome of meiosis to achieve overrepresentation in the progeny, thus increasing their likelihood of invading and propagating in a population. In P. anserina there are multiple meiotic drivers but their genetic basis was previously unknown.
    [Show full text]
  • How Do Yeast Cells Contend with Prions?
    International Journal of Molecular Sciences Review How Do Yeast Cells Contend with Prions? Reed B. Wickner *, Herman K. Edskes, Moonil Son, Songsong Wu and Madaleine Niznikiewicz Laboratory of Biochemistry and Genetics, National Institute of Diabetes Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892-0830, USA; [email protected] (H.K.E.); [email protected] (M.S.); [email protected] (S.W.); [email protected] (M.N.) * Correspondence: [email protected]; Tel.: +1-301-496-3452 Received: 15 June 2020; Accepted: 30 June 2020; Published: 3 July 2020 Abstract: Infectious proteins (prions) include an array of human (mammalian) and yeast amyloid diseases in which a protein or peptide forms a linear β-sheet-rich filament, at least one functional amyloid prion, and two functional infectious proteins unrelated to amyloid. In Saccharomyces cerevisiae, at least eight anti-prion systems deal with pathogenic amyloid yeast prions by (1) blocking their generation (Ssb1,2, Ssz1, Zuo1), (2) curing most variants as they arise (Btn2, Cur1, Hsp104, Upf1,2,3, Siw14), and (3) limiting the pathogenicity of variants that do arise and propagate (Sis1, Lug1). Known mechanisms include facilitating proper folding of the prion protein (Ssb1,2, Ssz1, Zuo1), producing highly asymmetric segregation of prion filaments in mitosis (Btn2, Hsp104), competing with the amyloid filaments for prion protein monomers (Upf1,2,3), and regulation of levels of inositol polyphosphates (Siw14). It is hoped that the discovery of yeast anti-prion systems and elucidation of their mechanisms will facilitate finding analogous or homologous systems in humans, whose manipulation may be useful in treatment.
    [Show full text]
  • Signature Redacted. Amy E
    A genetic platform for the study of protein perturbation and prion-based inheritance by Gregory A. Newby B.S., Biological Sciences Carnegie Mellon University (2009) SUBMITTED TO THE DEPARTMENT OF BIOLOGY IN PARTIAL FULFILLMENT OF THE REQUIREMENTS FOR THE DEGREE OF DOCTOR OF PHILOSOPHY AT THE MASSACHUSETTS INSTITUTE OF TECHNOLOGY June 2017 Massachusetts Institute of Technology 2017. All rights reserved. Signature redacted Signature of Author................................. Department of Biology redacted C e rtifie d B y .. Signature ............... I.R..... F..... / Gerald R. Fink Professor of Biology Acting Thesis Supervisor in Place of Susan Lipdquist (deceased) Accepted By............ Signature redacted. Amy E. Keating MASSACHUSETTS INSTITUTE Professor of Biology OF TECHNOLOGY Chair, Graduate Student Committee MAY 2 3 2017 LIBRARIES I 1 2 A genetic platform for the study of protein perturbation and prion-based inheritance By Gregory Arthur Newby Submitted to the Department of Biology in Partial Fulfillment of the Requirements for the Degree of Doctor of Philosophy in Biology SUMMARY Proteins mediate every cellular process. In order for life to exist, each protein must be finely tuned to carry out its function at the proper time and place. Because the environment is dynamic and often unpredictable, the regulation of proteins must be responsive to environmental stimuli. Mutations, age, and severe or repeated insults can decrease the quality of protein regulation, leading to disease. The study of protein regulation and its dysfunction in disease are of vital importance. Regulatory and disease phenomena involving protein assembly or aggregation are common but currently understudied on account of their intractability with existing techniques. In order to equip scientists with better tools to tackle these difficult phenomena, my collaborators Ahmad Khalil and Szilvia Kiriakov (Boston University) and I developed the yTRAP platform (standing for: yeast transcriptional reporters of aggregating proteins).
    [Show full text]
  • The Role of RNA in Prion Aggregation and Disease
    Digital Comprehensive Summaries of Uppsala Dissertations from the Faculty of Science and Technology 1620 The role of RNA in prion aggregation and disease PETAR STEFANOV KOVACHEV ACTA UNIVERSITATIS UPSALIENSIS ISSN 1651-6214 ISBN 978-91-513-0208-9 UPPSALA urn:nbn:se:uu:diva-338857 2018 Dissertation presented at Uppsala University to be publicly examined in A1:107a, BMC, Husargatan 3, Uppsala, Friday, 2 March 2018 at 09:00 for the degree of Doctor of Philosophy. The examination will be conducted in English. Faculty examiner: Associate professor Magnus Wolf-Watz (Department of Chemistry, Umeå University). Abstract Kovachev, P. S. 2018. The role of RNA in prion aggregation and disease. Digital Comprehensive Summaries of Uppsala Dissertations from the Faculty of Science and Technology 1620. 81 pp. Uppsala: Acta Universitatis Upsaliensis. ISBN 978-91-513-0208-9. As humanity evolved to witness an exceptionally high standard of living, Alzheimer’s, cancer and diabetes gradually replaced infections as the main limiting factors in longevity. It is both disturbing and captivating that such degenerative conditions are caused by the most ubiquitous biomolecule – the protein. Indeed, proteins are not only the most functional, but also the least understood of the cellular biopolymers. It is then not surprising that many severe human ailments are associated with aberrant proteostasis. The key, causative mechanism of proteinopathy is protein aggregation. Naturally occurring and sometimes functional, aggregation is an auxiliary pathway in protein folding. In the context of a crowded cellular environment, folding and aggregation are the least and one of the least understood molecular processes, respectively. Unravelling one can help deconstruct the other and vice versa, but also can provide mechanistic insight on degenerative proteinopathies.
    [Show full text]
  • What Makes a Prion: Infectious Proteins from Animals to Yeast Kyle S
    University of New Hampshire University of New Hampshire Scholars' Repository Life Sciences Faculty Scholarship Life Sciences 10-20-2016 What Makes a Prion: Infectious Proteins From Animals to Yeast Kyle S. MacLea University of New Hampshire, Manchester, [email protected] Follow this and additional works at: https://scholars.unh.edu/unhmbiology_facpub Recommended Citation MacLea, K.S. What makes a prion: Infectious proteins from animals to yeast. Int Rev Cell Mol Biol, 329:227-276, doi: 10.1016/ bs.ircmb.2016.08.012, 2017. This Article is brought to you for free and open access by the Life Sciences at University of New Hampshire Scholars' Repository. It has been accepted for inclusion in Life Sciences Faculty Scholarship by an authorized administrator of University of New Hampshire Scholars' Repository. For more information, please contact [email protected]. 1 What Makes a Prion: Infectious Proteins From Animals to Yeast 2 3 Kyle S. MacLea 4 5 Department of Life Sciences, University of New Hampshire, Manchester, New Hampshire 6 7 8 9 10 11 Running title: Infectious Proteins from Animals to Yeast 12 13 14 15 Corresponding Author: Dr. Kyle S. MacLea 16 Department of Life Sciences 17 University of New Hampshire 18 Manchester, NH 03101 19 20 Tel: 603-641-4129 21 Fax: 603-641-4303 22 e-mail: [email protected] 23 24 25 2 Tables, 4 Figures 26 27 28 Abbreviations: TSE, transmissible spongiform encephalopathy; BSE, bovine spongiform 29 encephalopathy; CWD, chronic wasting disease; CJD, Creutzfeldt-Jakob disease; FFI, 30 fatal familial insomnia; MBM, meat and bone meal; ALS, amyotrophic lateral sclerosis; 31 FTLD, frontotemporal lobar degeneration; MSA, multiple system atrophy; TMV, tobacco 32 mosaic virus; PrP, prion protein; PFD, prion-forming domain; PrLD, prion-like domain; 33 ND, nucleation domain; ORD, oligopeptide repeat domain; PrP, mammalian prion 34 protein; HMM, hidden Markov model; GFP, green fluorescent protein; ORF, open 35 reading frame.
    [Show full text]
  • The HET-S/S Prion Motif in the Control of Programmed Cell Death
    Downloaded from http://cshperspectives.cshlp.org/ on September 30, 2021 - Published by Cold Spring Harbor Laboratory Press The HET-S/s Prion Motif in the Control of Programmed Cell Death Roland Riek1 and Sven J. Saupe2 1Laboratory of Physical Chemistry, ETH Zu¨rich, 8093 Zu¨rich, Switzerland 2Institut de Biochimie et de Ge´ne´tique Cellulaire UMR 5095, CNRS - Universite´ de Bordeaux, 33077 Bordeaux, France Correspondence: [email protected]; [email protected] The [Het-s] prion of the fungus Podospora anserina is a well-studied model system to eluci- date the action of prions and beyond. The [Het-s] prion works as an activation trigger of a cell death execution protein termed HET-S. Amyloid transconformation of the prion-forming region of HET-S induces activation of its pore-forming cell death execution HeLo domain. The prion motif functions in a signal transduction process by which a nucleotide-binding oligomerization domain (NOD)-like receptor termed NWD2 controls the HET-S cell death effector. This prion motif thus corresponds to a functional amyloid motif, allowing a confor- mational crosstalk between homologous motif domains in signal transduction processes that appears to be widespread from the fungal to the mammalian animal kingdoms. This review aims to establish a structure–activity relationship of the HET-S/s prion system and sets it in the context of its wider biological significance. myloids are generally perceived as patholog- Podospora anserina. Upon prion formation, the Aical protein aggregates because they cause HET-s prion-forming domain (PFD) under- devastating neurodegenerative diseases in hu- goes a transition from an unordered flexible mans (Jucker and Walker 2013).
    [Show full text]
  • On the Evolution of Allorecognition and Somatic Fusion in Ascomycete Filamentous Fungi
    On the evolution of allorecognition and somatic fusion in ascomycete filamentous fungi Eric Bastiaans Thesis committee Promotor Prof. Dr B.J. Zwaan Professor of Genetics Wageningen University Co-promotors Dr D.K. Aanen Assistant professor, Laboratory of Genetics Wageningen University Dr A.J.M. Debets Associate professor, Laboratory of Genetics Wageningen University Other members Prof. Dr T.W. Kuyper, Wageningen University Prof. Dr H. Wösten, Utrecht University Prof. Dr N.P.R. Anten, Wageningen University Prof. Dr L. Sundström, University of Helsinki, Finland This research was conducted under the auspices of the C.T. de Wit Graduate School for Production Ecology and Resource Conservation On the evolution of allorecognition and somatic fusion in ascomycete filamentous fungi Eric Bastiaans Thesis submitted in fulfilment of the requirements for the degree of doctor at Wageningen University by the authority of the Rector Magnificus Prof. Dr M.J. Kropff, in the presence of the Thesis Committee appointed by the Academic Board to be defended in public on Wednesday 27 May 2015 at 4 p.m. in the Aula. Eric Bastiaans On the evolution of allorecognition and somatic fusion in ascomycete filamentous fungi 128 pages. PhD thesis, Wageningen University, Wageningen, NL (2015) With references, with summaries in Dutch and English ISBN 978-94-6257-297-3 Contents Chapter 1 7 General introduction Chapter 2 19 Experimental demonstration of the benefits of somatic fusion and the consequences for allorecognition Chapter 3 35 High relatedness protects multicellular
    [Show full text]
  • Discovery and Characterization of Prions in Saccharomyces Cerevisiae
    Discovery and Characterization of Prions in Saccharomyces cerevisiae by Randal A. Halfmann B.S. Genetics Texas A&M University, 2004 Submitted to the Department of Biology in partial fulfillment of the requirements for the degree of DOCTOR OF PHILOSOPHY IN BIOLOGY at the MASSACHUSETTS INSTITUTE OF TECHNOLOGY FEBRUARY 2011 © 2011 Randal A. Halfmann. All rights reserved. The author hereby grants to MIT permission to reproduce and to distribute publicly paper and electronic copies of this thesis document in whole or in part in any medium now known or hereafter created Signature of Author:_________________________________________________________________________________ Department of Biology December 3, 2010 Certified by:___________________________________________________________________________________________ Susan L. Lindquist Professor of Biology Thesis Supervisor Accepted by:__________________________________________________________________________________________ Stephen P. Bell Professor of Biology Co-Chair, Biology Graduate Committee 1 2 Discovery and Characterization of Prions in Saccharomyces cerevisiae by Randal A. Halfmann Submitted to the Department of Biology in partial fulfillment of the requirements for the Degree of Doctor of Philosophy in Biology ABSTRACT Some protein aggregates can perpetuate themselves in a self-templating protein-misfolding reaction. These aggregates, or prions, are the infectious agents behind diseases like Kuru and mad- cow disease. In yeast, however, prions act as epigenetic elements that confer heritable alternative phenotypes. Prion-forming proteins create bistable molecular systems whose semi-stochastic switching between functional states increases phenotypic diversity within cell populations. My thesis work explores the idea that rather than being detrimental, prions may commonly act to their host’s advantage. To broaden the known range of prion phenomena in S. cerevisiae, I, together with a postdoctoral fellow in our lab, systematically surveyed the yeast proteome for prion-forming proteins.
    [Show full text]